Switzerland Boosts COVID-19 Vaccine Fund To 400 Million Swiss Francs
ZURICH: Switzerland increased funds it has set aide to buy vaccines against COVID-19 to 400 million Swiss francs ($436 million), from 300 million francs previously, saying on Wednesday the additional infusion is necessary to ensure it can get supplies it needs.
Switzerland has already reserved nearly 10 million doses of prospective vaccines from Moderna and AstraZeneca that are now in late-stage trials. It is also in talks with additional manufacturers as it hopes to give first shots against the new coronavirus in the first half of 2021, should one be approved by national regulators.
($1 = 0.9171 Swiss francs)
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor
Stay connected with us on social media platform for instant update click here to join our ????️????️ Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Business headlines.
For all the latest Business News Click Here
For the latest news and updates, follow us on Google News.
Also, if you like our efforts, consider sharing this story with your friends, this will encourage us to bring more exciting updates for you.
